Learning : Short Courses

 
 


Adaptive Clinical Trials

Scott S. Emerson, MD, PhD

November, 2010

Abstract: Increasingly, clinical trials are conducted using group sequential methods and, more recently, adaptive clinical trial designs in order to address the ethical and efficiency issues that arise when performing experiments with human volunteers. The design, conduct, and analysis of a sequential clinical trial is necessarily more involved than that for a clinical trial in which the data would only be analyzed at the end of the study. However, the basic tenets of careful consideration of the scientific question and clinical setting remains the same. In this short course we present an overview of the issues that must be considered when conducting any sequential trial, and contrast the more commonly used group sequential approach to the various forms of adaptive designs that have been described in the statistical literature.






Course Materials (pdf):               Presentation Handouts


Learning Material:


  1. Short Courses

  2. Research Talks

  3. Case Studies


1. Introduction and Overview: 
Scientific design of clinical trials
(Slides:1-47) (60:59)

2. Phases of Investigation: 
Definition of an “indication”; Phase I, II, III, IV trials
(Slides:48-56) (7:52)

3. Confirmatory Trials: 
Motivating the need for confirmatory phase III trials
(Slides:57-66) (15:46)

4. Efficacy vs Effectiveness: 
Definition of efficacy and effectiveness trials; RCT settings where effectiveness might be preferred
(Slides:67-78) (12:03)

5. Screening Trials: 
Phase II as screening trials, Phase I, IV trials
(Slides:79-97) (29:07)



http://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRHAdaptive-2010-11-08-Overview/CDRHAdaptive-2010-11-08-Overview.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Phases%20of%20Investigation/CDRH-2011-11-08-Phases%20of%20Investigation.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Confirmatory%20Trials/CDRH-2011-11-08-Confirmatory%20Trials.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Efficacy%20vs%20Effectiveness/CDRH-2011-11-08-Efficacy%20vs%20Effectiveness.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Screening%20Trials/CDRH-2011-11-08-Screening%20Trials.htmlhttp://www.rctdesign.org/shortcourses/cberOctober2009/cber20091015-Refining%20Scientific%20Hypotheses/cber20091015-Refining%20Scientific%20Hypotheses.htmlshapeimage_3_link_0shapeimage_3_link_1shapeimage_3_link_2shapeimage_3_link_3shapeimage_3_link_4
6. Motivating Example: 
Progression from phase II to phase III; Selection of stopping rules
(Slides:98-111) (29:48)

7. Study Precision: 
Statistical design, sample size determination
(Slides:112-136) (32:22)

8. Group Sequential Designs - O'Brien-Fleming Efficacy Boundaries: 
Effect of O'Brien-Fleming efficacy boundaries on power, sample size requirements
(Slides:137-148) (22:23)

9. Group Sequential Designs - Futility Boundaries: 
Effect of futility boundaries on power, sample size requirements; correspondence to conditional/predictive power
(Slides:149-160) (6:32)



http://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Motivating%20Example/CDRH-2011-11-08-Motivating%20Example.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Study%20Precision/CDRH-2011-11-08-Study%20Precision.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-OBrien-Fleming%20Efficacy%20Boundary/CDRH-2011-11-08-OBrien-Fleming%20Efficacy%20Boundary.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-OBrien-Fleming%20Efficacy%20Boundary/CDRH-2011-11-08-OBrien-Fleming%20Efficacy%20Boundary.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Futility%20Boundaries/CDRH-2011-11-08-Futility%20Boundaries.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Futility%20Boundaries/CDRH-2011-11-08-Futility%20Boundaries.htmlhttp://www.rctdesign.org/shortcourses/cberOctober2009/cber20091015-Scientific%20Burden%20of%20Evidence/cber20091015-Scientific%20Burden%20of%20Evidence.htmlshapeimage_4_link_0shapeimage_4_link_1shapeimage_4_link_2shapeimage_4_link_3shapeimage_4_link_4shapeimage_4_link_5
10. Group Sequential Designs - Efficient Boundaries: 
Effect of increasing number of analyses; optimal boundary shapes
(Slides:161-173) (14:59)

11. Response Adaptive Modifications: 
Results of Proschan & Hunsberger; Reweighting incremental statistics
(Slides:174-187) (27:30)

12. Modification of Maximal Sample Size: 
Efficient response adaptive modification of the maximal sample size
(Slides:188-198) (18:41)

13. Comments on example from Mehta and Pocock: 
Discussion of a manuscript that appeared in Statistics in Medicine
(Slides II:199-204) (17:36)

14. Final Comments: 
Cost of planning not to plan; Other adaptive applications; Final comments
(Slides:205-240) (16:46)

http://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Efficient%20Boundaries/CDRH-2011-11-08-Efficient%20Boundaries.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Efficient%20Boundaries/CDRH-2011-11-08-Efficient%20Boundaries.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Response%20Adaptive%20Modifications/CDRH-2011-11-08-Response%20Adaptive%20Modifications.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Modification%20of%20Maximal%20Sample%20Size/CDRH-2011-11-08-Modification%20of%20Maximal%20Sample%20Size.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Example%20from%20Mehta%20and%20Pocock/CDRH-2011-11-08-Example%20from%20Mehta%20and%20Pocock.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Example%20from%20Mehta%20and%20Pocock/CDRH-2011-11-08-Example%20from%20Mehta%20and%20Pocock.htmlhttp://www.rctdesign.org/shortcourses/cdrhNovember2010/CDRH-2011-11-08-Final%20Comments/CDRH-2011-11-08-Final%20Comments.htmlhttp://www.rctdesign.org/shortcourses/cberOctober2009/cber20091015-Scientific%20Review%20of%20Clinical%20Trial%20Design/cber20091015-Scientific%20Review%20of%20Clinical%20Trial%20Design.htmlshapeimage_5_link_0shapeimage_5_link_1shapeimage_5_link_2shapeimage_5_link_3shapeimage_5_link_4shapeimage_5_link_5shapeimage_5_link_6

Video Slideshows: